Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284

MLA

John Mo, et al. “Pharmacokinetics, Pharmacodynamics and Safety of the Inverse Retinoic Acid‐related Orphan Receptor γ Agonist AZD0284.” British Journal of Clinical Pharmacology, vol. 86, Mar. 2020, pp. 1398–405. EBSCOhost, https://doi.org/10.1111/bcp.14253.

APA

John Mo, David J. Keeling, Robert Palmér, Marita Olsson, Christina Lundin, Muir Russell, Rikard Pehrson, Henrik Forsman, David Close, Sara Asimus, Sara Carlert, & Muna Albayaty. (2020). Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284. British Journal of Clinical Pharmacology, 86, 1398–1405. https://doi.org/10.1111/bcp.14253

Chicago

John Mo, David J. Keeling, Robert Palmér, Marita Olsson, Christina Lundin, Muir Russell, Rikard Pehrson, et al. 2020. “Pharmacokinetics, Pharmacodynamics and Safety of the Inverse Retinoic Acid‐related Orphan Receptor γ Agonist AZD0284.” British Journal of Clinical Pharmacology 86 (March): 1398–1405. doi:10.1111/bcp.14253.